Novozymes A/S
XMUN:NZM2
Novozymes A/S
XMUN:NZM2
Price:
56.44
EUR
-0.53%
Market Closed
Market Cap:
€15.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novozymes A/S
XMUN:NZM2
|
DK |
|
S
|
Standard Motor Products Inc
F:SRU
|
US |
|
Silvercrest Asset Management Group Inc
NASDAQ:SAMG
|
US |
|
T
|
T-Mobile US Inc
XETRA:TM5
|
US |
|
T
|
Teradyne Inc
DUS:TEY
|
US |
|
PureTech Health PLC
LSE:PRTC
|
US |
|
Golar LNG Ltd
NASDAQ:GLNG
|
BM |
|
H
|
Hisense Home Appliances Group Co Ltd
XMUN:GKE
|
CN |
|
E ON SE
MIL:EOAN
|
DE |
|
S
|
Scotts Miracle-Gro Co
SWB:SCQA
|
US |
|
B
|
Brambles Ltd
OTC:BXBLY
|
AU |
|
G
|
Global Payments Inc
SWB:GLO
|
US |
|
Hong Kong and China Gas Co Ltd
OTC:HOKCY
|
HK |
|
A
|
AIA Group Ltd
OTC:AAGIY
|
HK |
|
Smith & Wesson Brands Inc
NASDAQ:SWBI
|
US |
|
Japan Post Bank Co Ltd
OTC:JPSTF
|
JP |
|
UBS Group AG
SIX:UBSG
|
CH |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of NZM2.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NZM2
Multiples-Based Value
Base Case
Not Available
